Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Raman

Showing results (311-320 of 455) with videos related to

Pageof 46
Sort By:
Urologic Oncology|May 16, 2018
Predicting morbidity after robotic partial nephrectomy: The effect of tumor, environment, and patient-related factorsZine-Eddine Khene, Benoit Peyronnet, Neil J Kocher, et al.
The Journal of Urology|November 27, 2016
A Multi-Institutional Comparison of Clinicopathological Characteristics and Oncologic Outcomes of Upper Tract Urothelial Carcinoma in China and the United StatesNirmish Singla, Dong Fang, Xiaohong Su, et al.
Oncogenesis|November 28, 2019
Repression of transcription factor AP-2 alpha by PPARγ reveals a novel transcriptional circuit in basal-squamous bladder cancerHironobu Yamashita, Yuka I Kawasawa, Lauren Shuman, et al.
Urologic Oncology|April 4, 2017
Clinical comparison of noninvasive urine tests for ruling out recurrent urothelial carcinomaYair Lotan, Paul OʼSullivan, Jay D Raman, et al.
The Journal of Urology|November 16, 2010
Chronic kidney disease before and after partial nephrectomyMelanie A Clark, Sergey Shikanov, Jay D Raman, et al.
Scientific Reports|October 3, 2022
A transcriptional network of cell cycle dysregulation in noninvasive papillary urothelial carcinomaJoshua I Warrick, Margaret A Knowles, Carolyn D Hurst, et al.
Urologic Oncology|November 28, 2017
Preoperative predictors of nonorgan-confined disease in upper-tract urothelial carcinoma differ between China and the United StatesNirmish Singla, Dong Fang, Xiaohong Su, et al.
European Urology Oncology|July 13, 2023
The Selection for Cytoreductive Nephrectomy (SCREEN) Score: Improving Surgical Risk Stratification by Integrating Common Radiographic FeaturesE Jason Abel, Viraj A Master, Philippe E Spiess, et al.
The Journal of Urology|November 19, 2024
Long-Term Outcomes of Primary Chemoablation of Low-Grade Upper Tract Urothelial Carcinoma With UGN-101, a Mitomycin Reverse Thermal GelPhillip M Pierorazio, Nir Kleinmann, Ahmad Shabsigh, et al.
European Urology Oncology|November 24, 2023
Reply to Eduard Roussel, Riccardo Bertolo, Chiara Ciccarese, et al's Letter to the Editor re: E. Jason Abel, Viraj A. Master, Philippe E. Spiess, et al. The Selection for Cytoreductive Nephrectomy (SCREEN) Score: Improving Surgical Risk Stratification by Integrating Common Radiographic Features. Eur Urol Oncol. 2023;6:266-274E Jason Abel, Viraj A Master, Philippe E Spiess, et al.
Pageof 46

Showing results (311-320 of 455) with videos related to

Sort By:
Pageof 46
Urologic Oncology|May 16, 2018
Predicting morbidity after robotic partial nephrectomy: The effect of tumor, environment, and patient-related factorsZine-Eddine Khene, Benoit Peyronnet, Neil J Kocher, et al.
The Journal of Urology|November 27, 2016
A Multi-Institutional Comparison of Clinicopathological Characteristics and Oncologic Outcomes of Upper Tract Urothelial Carcinoma in China and the United StatesNirmish Singla, Dong Fang, Xiaohong Su, et al.
Oncogenesis|November 28, 2019
Repression of transcription factor AP-2 alpha by PPARγ reveals a novel transcriptional circuit in basal-squamous bladder cancerHironobu Yamashita, Yuka I Kawasawa, Lauren Shuman, et al.
Urologic Oncology|April 4, 2017
Clinical comparison of noninvasive urine tests for ruling out recurrent urothelial carcinomaYair Lotan, Paul OʼSullivan, Jay D Raman, et al.
The Journal of Urology|November 16, 2010
Chronic kidney disease before and after partial nephrectomyMelanie A Clark, Sergey Shikanov, Jay D Raman, et al.
Scientific Reports|October 3, 2022
A transcriptional network of cell cycle dysregulation in noninvasive papillary urothelial carcinomaJoshua I Warrick, Margaret A Knowles, Carolyn D Hurst, et al.
Urologic Oncology|November 28, 2017
Preoperative predictors of nonorgan-confined disease in upper-tract urothelial carcinoma differ between China and the United StatesNirmish Singla, Dong Fang, Xiaohong Su, et al.
European Urology Oncology|July 13, 2023
The Selection for Cytoreductive Nephrectomy (SCREEN) Score: Improving Surgical Risk Stratification by Integrating Common Radiographic FeaturesE Jason Abel, Viraj A Master, Philippe E Spiess, et al.
The Journal of Urology|November 19, 2024
Long-Term Outcomes of Primary Chemoablation of Low-Grade Upper Tract Urothelial Carcinoma With UGN-101, a Mitomycin Reverse Thermal GelPhillip M Pierorazio, Nir Kleinmann, Ahmad Shabsigh, et al.
European Urology Oncology|November 24, 2023
Reply to Eduard Roussel, Riccardo Bertolo, Chiara Ciccarese, et al's Letter to the Editor re: E. Jason Abel, Viraj A. Master, Philippe E. Spiess, et al. The Selection for Cytoreductive Nephrectomy (SCREEN) Score: Improving Surgical Risk Stratification by Integrating Common Radiographic Features. Eur Urol Oncol. 2023;6:266-274E Jason Abel, Viraj A Master, Philippe E Spiess, et al.
Pageof 46